A Profitable Diagnosis on Health-care Investing
Investing can be fun and profitable at times, but it also can be tricky. There are hundreds, if not thousands, of companies to choose from in dozens and dozens of industries. Some are new and thriving like wireless, broadband and social media. That’s great for companies like Qualcomm (QCOM), Entropic (ENTR) and Facebook (FB), as well as their shareholders. Others like newspapers such as the New York Times (NYT), book publishers and retail book stores like Barnes & Noble (BKS) are feeling the pain as their industries adapt to what I call the Always On, Always Connected society.
The economy and industry fundamentals are not the only thing to watch and listen to with your investing eyes and ears. One other aspect is the regulatory environment and more specifically new regulations. As we know, business has been saddled with a number of them over the last few years, but none have the ability to impact the cost structure of a business like the Affordable Care Act, which is more commonly known as Obamacare.
We’ve done a few PowerTalks already that have looked at the implications of Obamacare and other regulations. This week, we’re talking about how you can profit from these regulations.
Joining me this week on PowerTalk are George Abraham and Sumesh Sood of Veda Healthcare Partners. Veda is a hedge fund that has been in operation for more than two and a half years and invests in healthcare. From biotech and pharmaceuticals to managed care and generic drugs, these guys are looking at all of it with an eye toward delivering profits for their investors.
Health-care investing can be a tricky thing, but when we look around and see just the shifting demographics — living longer, a heavier population, nutritional concerns and more — it’s apparent that there are a number of pain points. For me, pain points mean opportunity for the prepared investor. Let’s listen to what George and Sumesh see as remedies for not only these issues but also for your wallet.
Listen to my behind-the-scenes PowerTalk conversation now, so you are even more in the know:
Special introductory offer: Right now you can try Chris Versace’s PowerTrend Profits risk-free for only $99.95! Find out how, here.
Access prior PowerTalk interviews here:
Press Contact: Alberto Rojas (202) 677-4474 * firstname.lastname@example.org